Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans.

Hidden Markov models in computational biology. Applications to protein modeling. J Mol Biol (1994) 31.57

Global and societal implications of the diabetes epidemic. Nature (2001) 25.18

Dirichlet mixtures: a method for improved detection of weak but significant protein sequence homology. Comput Appl Biosci (1996) 19.74

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell (2000) 11.10

Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74

Glucose tolerance in adults after prenatal exposure to famine. Lancet (1998) 8.87

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia (1993) 8.86

Objective structured assessment of technical skill (OSATS) for surgical residents. Br J Surg (1997) 7.54

Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med (1994) 6.59

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40

Local research ethics committees. BMJ (1995) 6.30

Stochastic context-free grammars for tRNA modeling. Nucleic Acids Res (1994) 6.29

Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature (1984) 6.06

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature (1985) 5.10

Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell (1986) 4.89

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71

Medical errors: a common problem. BMJ (2001) 4.69

An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol (1972) 4.42

Growth in utero and serum cholesterol concentrations in adult life. BMJ (1993) 4.34

A Social Study of Hospital Treatment. Br Med J (1945) 4.24

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science (1994) 4.22

Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease. BMJ (1992) 4.18

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14

Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev (2000) 4.01

Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90

The association of school environments with youth physical activity. Am J Public Health (2001) 3.88

Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet (2011) 3.70

Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ (1990) 3.65

Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J (1978) 3.54

Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet (2000) 3.53

Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med (1995) 3.34

Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34

Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33

lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell (1987) 3.33

Multicentre research ethics committees: has the cure been worse than the disease? No, but idiosyncracies and obstructions to good research must be removed. BMJ (2000) 3.18

Thinness at birth and insulin resistance in adult life. Diabetologia (1994) 3.15

Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem (1995) 3.13

Cost comparison: a desflurane- versus a propofol-based general anesthetic technique. Anesth Analg (1994) 3.09

Fetal growth and impaired glucose tolerance in men and women. Diabetologia (1993) 3.09

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer (2003) 3.06

Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A (1991) 3.06

Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med (1980) 3.04

Insulin resistance in microvascular angina (syndrome X) Lancet (1993) 3.02

Introduction and audit of a general practice antibiotic formulary. J R Coll Gen Pract (1988) 3.00

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther (2000) 2.94

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2004) 2.94

Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem (1978) 2.93

Assessment of technical skills transfer from the bench training model to the human model. Am J Surg (1999) 2.90

The urethral pressure profile. Br J Urol (1969) 2.88

Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia. Lancet (1976) 2.84

The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet (1985) 2.77

Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74

Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet (1989) 2.69

Insulin deficiency in non-insulin-dependent diabetes. Lancet (1989) 2.61

Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58

p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 2.58

Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ (1995) 2.57

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J (1978) 2.57

The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med (1995) 2.56

Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine beta-hydroxylase. Neuroscience (1980) 2.55

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A (1997) 2.54

Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens (2000) 2.54

Fetal and infant growth and cardiovascular risk factors in women. BMJ (1995) 2.52

Size at birth, maternal weight, and type 2 diabetes in South India. Diabet Med (1998) 2.50

Vertical integration: exploration of a popular strategic concept. Health Care Manage Rev (1986) 2.50

Training in academic medicine: a way forward for the new millennium. A discussion document from the Academic Medicine Committee of the Royal College of Physicians. J R Coll Physicians Lond (1999) 2.42

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol (2001) 2.42

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol (1997) 2.40

Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs. Arch Intern Med (1993) 2.36

Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36

Angiogenesis in skeletal and cardiac muscle. Physiol Rev (1992) 2.34

Cations and the secretion of insulin from rabbit pancreas in vitro. J Physiol (1968) 2.33

Cationic bactericidal peptides. Adv Microb Physiol (1995) 2.33

Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia (1995) 2.33

Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc Natl Acad Sci U S A (1999) 2.30

Induction of DNA polymerase in mouse L cells. J Mol Biol (1973) 2.28

The role of sodium and potassium in insulin secretion from rabbit pancreas. J Physiol (1968) 2.27

Initial effect of injury on ketone bodies and other blood metabolites. Lancet (1975) 2.27

The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci (1965) 2.26

Role of fetal and infant growth in programming metabolism in later life. Biol Rev Camb Philos Soc (1997) 2.23

Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20

The management of diabetes during surgery. Br J Anaesth (1979) 2.20

Immunoradiometric assay of parathyroid hormone. J Endocrinol (1971) 2.19

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol (2000) 2.18

Taste genes associated with dental caries. J Dent Res (2010) 2.17

Height and glucose tolerance in adult subjects. Diabetologia (1991) 2.17

The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia (1967) 2.17

Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med (1999) 2.17

Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med (1990) 2.16

Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16

Dangers of intravenous fructose. Lancet (1972) 2.15

Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet (1999) 2.14

Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg (2001) 2.13

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13